Standout Papers

Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota... 2021 2026 2022 2024224
  1. Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota (2021)
    Yan Wang, Qian Tong et al. Signal Transduction and Targeted Therapy
  2. Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota (2022)
    Shurong Ma, Qian Tong et al. Signal Transduction and Targeted Therapy

Immediate Impact

51 standout
Sub-graph 1 of 22

Citing Papers

Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis
2024 Standout
The oral–gut microbiome axis in health and disease
2024 Standout
4 intermediate papers

Works of Shurong Ma being referenced

Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
2021 Standout
Abnormal metabolism of gut microbiota reveals the possible molecular mechanism of nephropathy induced by hyperuricemia
2019
and 2 more

Author Peers

Author Last Decade Papers Cites
Shurong Ma 746 73 246 219 43 1.2k
Ran Peng 634 75 180 160 27 1.1k
Hang Yu 590 30 152 158 42 1.0k
Li‐Bin Pan 605 37 158 184 30 1.0k
Jiye Aa 1031 115 182 251 52 1.7k
Chenyue Liu 769 53 130 186 36 1.5k
Diling Chen 648 47 355 242 45 1.2k
Lin Cong 574 146 132 97 62 1.6k
Jiannan Chen 823 63 397 376 70 1.6k
Anchalee Pongchaidecha 557 37 132 128 36 1.4k
Jian Liang 555 37 309 149 37 1.4k

All Works

Loading papers...

Rankless by CCL
2026